{"id":"W1512461647","doi":"10.1067/mhj.2000.105107","title":"Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial","year":2000,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Heart Institute; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Eptifibatide; Myocardial infarction; Cardiology; Internal medicine; Stroke (engine); Vascular disease; Ticlopidine; Platelet activation; Unstable angina; Thienopyridine; Platelet aggregation inhibitor; Pharmacology; Platelet; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001750532,0.000852316,0.001897183,0.0002434565,0.0003565447,0.001492759,0.0005802867,0.001254557,0.00532741],"category_scores_gemma":[0.002213777,0.0003373724,0.0009345533,0.0002344316,0.000553181,0.0006532407,0.0003715839,0.002427435,0.001126058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004457463,"about_ca_system_score_gemma":0.0008276244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005408878,"about_ca_topic_score_gemma":0.001595563,"domain_scores_codex":[0.9988618,0.0006825876,0.00003539339,0.0001324158,0.00007990191,0.0002079604],"domain_scores_gemma":[0.9994138,0.0001830762,0.0001080268,0.00005456847,0.00003493861,0.0002055782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9134732,0.003658293,0.002745012,0.0006614268,0.002026844,0.0001130828,0.00008132178,0.001015617,0.004119241,0.003222183,0.006768716,0.06211511],"study_design_scores_gemma":[0.9277812,0.04585002,0.009187723,0.0001616617,0.001881253,0.000130557,0.00007181612,0.001027728,0.0007304327,0.003854885,0.009279922,0.00004274544],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9437168,0.01665321,0.003430305,0.006453597,0.003038021,0.002497464,0.001829913,0.0001872107,0.02219343],"genre_scores_gemma":[0.9792046,0.002876369,0.001869663,0.004742318,0.000980746,0.002502626,0.0009853181,0.00004119894,0.006797133],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.00532741,"threshold_uncertainty_score":0.01782197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01546911632974345,"score_gpt":0.2697006930554746,"score_spread":0.2542315767257312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}